Merit Medical Systems Stock Buy Hold or Sell Recommendation
| MMSI Stock | USD 73.78 0.40 0.55% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Merit Medical Systems is 'Hold'. Macroaxis provides Merit Medical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MMSI positions. The advice algorithm takes into account all of Merit Medical's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Merit Medical's buy or sell advice are summarized below:
Real Value 82.17 | Target Price 89.63 | Hype Value 73.6 | Market Value 73.78 | Naive Value 73.81 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Merit Medical Systems given historical horizon and risk tolerance towards Merit Medical. When Macroaxis issues a 'buy' or 'sell' recommendation for Merit Medical Systems, the advice is generated through an automated system that utilizes algorithms and statistical models.
Merit |
Execute Merit Medical Buy or Sell Advice
The Merit recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Merit Medical Systems. Macroaxis does not own or have any residual interests in Merit Medical Systems or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Merit Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Merit Medical Trading Alerts and Improvement Suggestions
| Merit Medical generated a negative expected return over the last 90 days | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Cardinal Health Reports Next Week Wall Street Expects Earnings Growth |
Merit Medical Returns Distribution Density
The distribution of Merit Medical's historical returns is an attempt to chart the uncertainty of Merit Medical's future price movements. The chart of the probability distribution of Merit Medical daily returns describes the distribution of returns around its average expected value. We use Merit Medical Systems price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Merit Medical returns is essential to provide solid investment advice for Merit Medical.
| Mean Return | -0.11 | Value At Risk | -1.83 | Potential Upside | 2.21 | Standard Deviation | 1.37 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Merit Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Merit Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Merit Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Merit Medical Systems backward and forwards among themselves. Merit Medical's institutional investor refers to the entity that pools money to purchase Merit Medical's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Loomis, Sayles & Company Lp | 2023-12-31 | 1.1 M | Aristotle Capital Boston, Llc | 2023-12-31 | 869.5 K | T. Rowe Price Associates, Inc. | 2023-12-31 | 816.8 K | Amvescap Plc. | 2023-12-31 | 801.2 K | Westwood Holdings Group Inc | 2023-12-31 | 748.4 K | Bank Of New York Mellon Corp | 2023-12-31 | 745.3 K | Channing Capital Management, Llc | 2023-12-31 | 728.2 K | Greenhouse Funds Lllp | 2023-09-30 | 719.5 K | Northern Trust Corp | 2023-12-31 | 713.7 K | Blackrock Inc | 2023-12-31 | 10 M | Vanguard Group Inc | 2023-12-31 | 6.9 M |
Merit Medical Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (27.0M) | 29.4M | (25.2M) | (47.9M) | (32.1M) | (30.5M) | |
| Change In Cash | (23.0M) | 12.6M | 10.8M | (7.2M) | 528.6M | 555.0M | |
| Free Cash Flow | (3.7M) | 116.0M | 119.3M | 69.3M | 108.5M | 113.9M | |
| Depreciation | 104.4M | 106.8M | 95.8M | 92.2M | 101.3M | 106.4M | |
| Other Non Cash Items | 26.8M | 31.0M | 9.4M | 15.9M | 10.8M | 11.3M | |
| Capital Expenditures | 81.5M | 49.3M | 27.9M | 45.0M | 36.7M | 29.4M | |
| Net Income | 5.5M | (9.8M) | 48.5M | 74.5M | 94.4M | 99.1M | |
| End Period Cash Flow | 44.3M | 56.9M | 67.8M | 60.6M | 589.1M | 618.6M | |
| Change To Netincome | 22.8M | 175.1M | 20.8M | 39.8M | 45.7M | 30.8M | |
| Investments | (134.5M) | 250K | (37.2M) | (57.4M) | (184.3M) | (175.1M) | |
| Net Borrowings | 44.5M | (88.4M) | (108.5M) | (44.9M) | (40.4M) | (38.4M) |
Merit Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Merit Medical or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Merit Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Merit stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.2 | |
β | Beta against NYSE Composite | 1.02 | |
σ | Overall volatility | 1.32 | |
Ir | Information ratio | -0.15 |
Merit Medical Volatility Alert
Merit Medical Systems exhibits very low volatility with skewness of -0.43 and kurtosis of 2.15. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Merit Medical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Merit Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Merit Medical Fundamentals Vs Peers
Comparing Merit Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Merit Medical's direct or indirect competition across all of the common fundamentals between Merit Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Merit Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Merit Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Merit Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Merit Medical to competition |
| Fundamentals | Merit Medical | Peer Average |
| Return On Equity | 0.0805 | -0.31 |
| Return On Asset | 0.0399 | -0.14 |
| Profit Margin | 0.08 % | (1.27) % |
| Operating Margin | 0.10 % | (5.51) % |
| Current Valuation | 4.58 B | 16.62 B |
| Shares Outstanding | 58.06 M | 571.82 M |
| Shares Owned By Insiders | 2.43 % | 10.09 % |
| Shares Owned By Institutions | 97.57 % | 39.21 % |
| Number Of Shares Shorted | 2.06 M | 4.71 M |
| Price To Earning | 956.67 X | 28.72 X |
| Price To Book | 3.51 X | 9.51 X |
| Price To Sales | 3.35 X | 11.42 X |
| Revenue | 1.25 B | 9.43 B |
| Gross Profit | 519.1 M | 27.38 B |
| EBITDA | 223.22 M | 3.9 B |
| Net Income | 94.41 M | 570.98 M |
| Cash And Equivalents | 51.48 M | 2.7 B |
| Cash Per Share | 0.91 X | 5.01 X |
| Total Debt | 891.36 M | 5.32 B |
| Debt To Equity | 0.26 % | 48.70 % |
| Current Ratio | 2.35 X | 2.16 X |
| Book Value Per Share | 20.77 X | 1.93 K |
| Cash Flow From Operations | 145.15 M | 971.22 M |
| Short Ratio | 5.61 X | 4.00 X |
| Earnings Per Share | 1.62 X | 3.12 X |
| Price To Earnings To Growth | 1.91 X | 4.89 X |
| Target Price | 93.6 | |
| Number Of Employees | 6.95 K | 18.84 K |
| Beta | 0.91 | -0.15 |
| Market Capitalization | 4.28 B | 19.03 B |
| Total Asset | 2.33 B | 29.47 B |
| Retained Earnings | 575.18 M | 9.33 B |
| Working Capital | 904.91 M | 1.48 B |
Note: Acquisition by Ward Lynne of 2262 shares of Merit Medical subject to Rule 16b-3 [view details]
Merit Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Merit . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Merit Medical Buy or Sell Advice
When is the right time to buy or sell Merit Medical Systems? Buying financial instruments such as Merit Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 315.0M | 268.8M | 891.4M | 935.9M | Total Assets | 1.6B | 1.7B | 2.3B | 2.4B |
Use Investing Ideas to Build Portfolios
In addition to having Merit Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Global Macro ETFs Thematic Idea Now
Global Macro ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Global Macro ETFs theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Global Macro ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Merit Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Merit Stock analysis
When running Merit Medical's price analysis, check to measure Merit Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merit Medical is operating at the current time. Most of Merit Medical's value examination focuses on studying past and present price action to predict the probability of Merit Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merit Medical's price. Additionally, you may evaluate how the addition of Merit Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Merit Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.17) | Earnings Share 1.62 | Revenue Per Share 21.832 | Quarterly Revenue Growth 0.106 | Return On Assets 0.0399 |
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.